• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Robert Gabbay Discusses Management of Pediatric Type 1, 2 Diabetes

Video

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, discusses some of the challenges of treating pediatric patients with type 1 or type 2 diabetes.

The American Diabetes Association (ADA) recognizes that type 2 diabetes in young people is a more severe disease, said Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the ADA.

Transcript

Section 14 of the ADA's 2022 Standards of Medical Care in Diabetes added new information about pediatric type 1 and type 2 diabetes. What is lacking in the care for children?

We recognize that particularly type 2 diabetes in young people is a more severe disease. It progresses more rapidly, and the risk of complications is higher. It's, in essence, a more aggressive disease, and so it's important that clinicians think about how to best manage those individuals and also to screen for them.

Young people with type 1 diabetes continue to be a challenging group and particularly young adults where, if anything, A1C [glycated hemoglobin], not only has it not gotten any better for that population, but it has gotten worse despite all of the technology that's become available. So it was important for us to emphasize the best management about type 1 and type 2 diabetes in children.

Related Videos
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
"Integrating New PAH Therapies into Clinical Practice"
Julie Patterson, PharmD, PhD
"Clinical Evidence for Emerging PAH Therapies"
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Michael Morse, MD, Duke Cancer Center
Dr Chris Pagnani
Screenshot of Angela Jia, MD, PhD, during a video interview
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.